Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk.
There is substantial epidemiologic data, but limited experimental data, supporting the mortality benefit of low-dose alcohol consumption. A regimen of a single, daily alcoholic beverage was sufficient to increase both high-density lipoprotein (HDL) (4.4%, p = 0.03) and HDL2 (7.7%, p = 0.04) in men and women, but did not significantly affect hemostatic markers of cardiovascular risk.
McConnell
M V
MV
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Vavouranakis
I
I
Wu
L L
LL
Vaughan
D E
DE
Ridker
P M
PM
D000328:Adult; D000428:Alcohol Drinking; D001515:Beer; D001779:Blood Coagulation Factors / Q000032:analysis*; D002318:Cardiovascular Diseases / Q000097:blood* / Q000453:epidemiology*; D008076:Cholesterol, HDL / Q000097:blood*; D005260:Female; D006801:Humans; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D008875:Middle Aged
D001779:Blood Coagulation Factors; D008076:Cholesterol, HDL; D008074:Lipoproteins